Literature DB >> 23792270

Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms.

Alla Keyzner1, Anita D'Souza, Martha Lacy, Morie Gertz, Suzanne Hayman, Francis Buadi, Shaji Kumar, David Dingli, Ann Engebretson, Caili Tong, Angela Dispenzieri.   

Abstract

A rare, multisystem, plasma cell neoplasm, POEMS (polyradiculoneuropathy, organomegaly, endocrinopathy, M-spike, skin changes) syndrome is characterized by an abundance of proinflammatory and angiogenic cytokines. Patients with POEMS are known to have a high incidence of engraftment syndrome after autologous stem cell transplantation. We conducted a pilot study assessing levels of 30 different pro- and anti-inflammatory cytokines before and serially after transplantation in 18 patients with plasma cell neoplasms: POEMS syndrome (n = 9), multiple myeloma (n = 4), and amyloidosis (n = 5). We show that POEMS patients have higher pretransplantation levels of IL-4, IL-10, IL-13, IFN-α, and EGF as compared with those with non-POEMS plasma cell neoplasms. Higher pre- and posttransplantation IL-13 levels correlated with delayed neutrophil engraftment in POEMS patients. Low posttransplantation IL-1RA levels correlated with engraftment syndrome in both POEMS and non-POEMS patients. We conclude that differences in the peri-transplantation cytokine milieu may explain the higher transplantation morbidity in patients with POEMS syndrome. Our results need validation in a larger cohort.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokines; IL-13; IL-1RA; Neutrophil engraftment

Mesh:

Substances:

Year:  2013        PMID: 23792270     DOI: 10.1016/j.bbmt.2013.06.012

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  4 in total

1.  Impact of pretransplant induction therapy on autologous stem cell transplantation for patients with newly diagnosed POEMS syndrome.

Authors:  J Li; M-H Duan; C Wang; X-F Huang; W Zhang; X-X Cao; T-N Zhu; J-L Zhuang; B Han; H Cai; H-C Cai; D-B Zhou
Journal:  Leukemia       Date:  2017-01-19       Impact factor: 11.528

2.  Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndrome.

Authors:  Taxiarchis V Kourelis; Dragan Jevremovic; Erik Jessen; Surendra Dasari; Jose C Villasboas; Angela Dispenzieri; Shaji Kumar
Journal:  Br J Haematol       Date:  2020-02-20       Impact factor: 6.998

3.  Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients.

Authors:  Damien Vitiello; Diana Chaar; Paul-Eduard Neagoe; Anique Ducharme; Michel Carrier; Guy B Pelletier; Normand Racine; Mark Liszkowski; Martin G Sirois; Michel White
Journal:  Vasc Cell       Date:  2015-04-22

4.  Pretreatment Serum Levels of IL-1 Receptor Antagonist and IL-4 Are Predictors of Overall Survival in Multiple Myeloma Patients Treated with Bortezomib.

Authors:  Damian Mikulski; Paweł Robak; Ewelina Perdas; Edyta Węgłowska; Aleksandra Łosiewicz; Izabela Dróżdż; Dariusz Jarych; Małgorzata Misiewicz; Janusz Szemraj; Wojciech Fendler; Tadeusz Robak
Journal:  J Clin Med       Date:  2021-12-26       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.